Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Stratafide™ CDx
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Illumina
Type:
Laboratory Developed Test
Related tests:
‹
TruSeq®Amplicon - Cancer Panel (5)
TruSight Oncology 500 Assay (3)
Praxis Extended RAS Panel (2)
Illumina Focus Panel
Illumina WGS MRD assay
TSO 500 ctDNA v2 Assay
TruSight Hereditary Cancer Panel
TruSight Myeloid Sequencing Panel
TruSight Oncology 500 HRD Assay
TruSight Oncology 500 ctDNA v2
TruSight Oncology Comprehensive
TruSight RNA Pan-Cancer Panel
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
TruSeq®Amplicon - Cancer Panel (5)
TruSight Oncology 500 Assay (3)
Praxis Extended RAS Panel (2)
Illumina Focus Panel
Illumina WGS MRD assay
TSO 500 ctDNA v2 Assay
TruSight Hereditary Cancer Panel
TruSight Myeloid Sequencing Panel
TruSight Oncology 500 HRD Assay
TruSight Oncology 500 ctDNA v2
TruSight Oncology Comprehensive
TruSight RNA Pan-Cancer Panel
TruSight Tumor 15 Assay
TruSight Tumor 170 Assay
›
Details
Evidence
News
STRATAFIDE CDx is a genomic sequencing in vitro diagnostic (IVD) cancer assay capable of identifying actionable genomic alterations in tissue or blood samples, including alterations targeted by emerging therapies undergoing clinical trials
Cancer:
Solid Tumor
Method:
Next-Generation Sequencing
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.